| 产品名称： | Human Coxsackievirus A 13 |
|---|---|
| 商品货号： | TS213516 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As： | Coxsackievirus A13 |
| Agent： | Human Coxsackievirus A 13 |
| Strain： | Flores |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | stool from a 23-month-old child, Mexico, 1952 derived from VR-1019, which was contributed by NIAID (V-016-001-312) |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | -70C or lower |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects (cell rounding, degeneration, sloughing) CPE (cell rounding, degeneration, sloughing) |
| Recommended Host： | HeLa cells (ATCC CCL-2) Host of Choice:xa0 HeLa (ATCC CCL-2) Host Range:xa0 HeLa, HAm, HED HeLa, HAm, HED |
| Growth Conditions： | Temperature: 37.0°C Duration: 2-5 days at 37C in HeLa cells (ATCC CCL-2) in BME + LEH + cystine + 1 M MgCl2 |
| Cryopreservation： | Storage temperature: -70C or lower |
| Name of Depositor： | ATCC |
| Special Collection： | NCRR Contract |
| Source： | stool from a 23-month-old child, Mexico, 1952 derived from VR-1019, which was contributed by NIAID (V-016-001-312) |
| Year of Origin： | 1952 |
| References： | Sickles GM, et al. Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc. Soc. Exp. Biol. Med. 90: 529-531, 1955. PubMed: 13273503 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Human Coxsackievirus A 13 |
|---|---|
| 商品货号： | TS213516 |
| Classification： | Picornaviridae, Enterovirus, Human enterovirus C |
| Deposited As： | Coxsackievirus A13 |
| Agent： | Human Coxsackievirus A 13 |
| Strain： | Flores |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | stool from a 23-month-old child, Mexico, 1952 derived from VR-1019, which was contributed by NIAID (V-016-001-312) |
| Product Format： | frozen |
| Storage Conditions： | -70°C or colder |
| Comments： | -70C or lower |
| Effect on Host： | Yes, in vitro effects: Cytopathic effects (cell rounding, degeneration, sloughing) CPE (cell rounding, degeneration, sloughing) |
| Recommended Host： | HeLa cells (ATCC CCL-2) Host of Choice:xa0 HeLa (ATCC CCL-2) Host Range:xa0 HeLa, HAm, HED HeLa, HAm, HED |
| Growth Conditions： | Temperature: 37.0°C Duration: 2-5 days at 37C in HeLa cells (ATCC CCL-2) in BME + LEH + cystine + 1 M MgCl2 |
| Cryopreservation： | Storage temperature: -70C or lower |
| Name of Depositor： | ATCC |
| Special Collection： | NCRR Contract |
| Source： | stool from a 23-month-old child, Mexico, 1952 derived from VR-1019, which was contributed by NIAID (V-016-001-312) |
| Year of Origin： | 1952 |
| References： | Sickles GM, et al. Recently classified types of Coxsackie virus, group A; behavior in tissue culture. Proc. Soc. Exp. Biol. Med. 90: 529-531, 1955. PubMed: 13273503 |
